Can online-onboard ART further improve classic IGRT in the Treatment of Patients with Prostate Cancer?

被引：0
|
作者：
Guberina, Nika [1 ]
Guberina, Maja [1 ]
Garcia, Alina Santiago [1 ]
Ringbaek, Toke Printz [1 ]
Poettgen, Christoph [1 ]
Khouya, Aymane [1 ]
Hlouschek, Julian [1 ]
Hoffmann, Christian [1 ]
Herz, Andreas [1 ]
Gauler, Thomas [1 ]
Fischedick, Gerrit [1 ]
Freisleben, Fabian [1 ]
Stuschke, Martin [1 ]
机构：
[1] Univ Klinikum Essen, Klin & Poliklin Strahlentherapie, Westdeutsch Tumorzentrum, Essen, Germany
来源：
STRAHLENTHERAPIE UND ONKOLOGIE | 2023年 / 199卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
VS15-6-jD
引用
收藏
页码：S52 / S53
页数：2
相关论文
共 50 条
  • [41] Can Pre-treatment Quantitative Multi- parametric MRI Predict the Outcome of Radiotherapy in Patients with Prostate Cancer?
    Chatterjee, Aritrick
    Turchan, William Tyler
    Fan, Xiaobing
    Griffin, Alexander
    Yousuf, Ambereen
    Karczmar, Gregory S.
    Liauw, Stanley L.
    Oto, Aytekin
    ACADEMIC RADIOLOGY, 2022, 29 (07) : 977 - 985
  • [42] WHAT CAN PATIENTS WITH PROSTATE CANCER EXPECT FROM TREATMENT WITH APALUTAMIDE? HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH METASTATIC CASTRATION-SENSITIVE PROSTATE CANCER IN THE PHASE 3 TITAN STUDY
    Lloyd, Jennifer
    Bevans, Katherine B.
    Dibaj, Shiva
    Brookman-May, Sabine D.
    ONCOLOGY NURSING FORUM, 2022, 49 (02) : 23 - 23
  • [43] Prostate cancer: in-bore magnetic resonance guided biopsies at active surveillance inclusion improve selection of patients for active treatment
    Elkjaer, Maria Carlsen
    Andersen, Morten Heeboll
    Hoyer, Soren
    Pedersen, Bodil Ginnerup
    Borre, Michael
    ACTA RADIOLOGICA, 2018, 59 (05) : 619 - 626
  • [44] Multiparametric magnetic resonance imaging of the prostate can improve the predictive value of the urinary prostate cancer antigen 3 test in patients with elevated prostate-specific antigen levels and a previous negative biopsy
    Sciarra, Alessandro
    Panebianco, Valeria
    Cattarino, Susanna
    Busetto, Gian Maria
    De Berardinis, Ettore
    Ciccariello, Mauro
    Gentile, Vincenzo
    Salciccia, Stefano
    BJU INTERNATIONAL, 2012, 110 (11) : 1661 - 1665
  • [45] Prebiopsy mp-MRI Can Help to Improve the Predictive Performance in Prostate Cancer: A Prospective Study in 1,478 Consecutive Patients
    Wang, Rui
    Wang, Jing
    Gao, Ge
    Hu, Juan
    Jiang, Yuanyuan
    Zhao, Zhenlong
    Zhang, Xiaodong
    Zhang, Yu-Dong
    Wang, Xiaoying
    CLINICAL CANCER RESEARCH, 2017, 23 (14) : 3692 - 3699
  • [46] Which tools can I use in daily clinical practice to improve tailoring of treatment for breast cancer? The 2007 St Gallen guidelines and/or Adjuvant! Online
    Cufer, T.
    ANNALS OF ONCOLOGY, 2008, 19 : 41 - 45
  • [47] DOES LOCAL TREATMENT OF THE PRIMARY TUMOR IMPROVE SURVIVAL OF METASTATIC PROSTATE CANCER PATIENTS? RESULTS FROM A POPULATION-BASED STUDY
    Fossati, Nicola
    Quoc-Dien Trinh
    Sammon, Jesse
    Sood, Akshay
    Larcher, Alessandro
    Sun, Maxine
    Karakiewicz, Pierre I.
    Guazzoni, Giorgio
    Montorsi, Francesco
    Briganti, Alberto
    Menon, Mani
    Abdollah, Firas
    JOURNAL OF UROLOGY, 2015, 193 (04): : E1039 - E1039
  • [48] Modified American Joint Committee on Cancer Tumor-Node-Metastasis Staging System Based on the Node Ratio Can Further Improve the Capacity of Prognosis Assessment for Gastric Cancer Patients
    Yang, Ze-Long
    Zhu, Ming-Hua
    Han, Xiu-Jing
    Liu, Qiang-Wei
    Long, Jian-Hai
    Wang, Chun-Xi
    FRONTIERS IN ONCOLOGY, 2019, 9
  • [49] Postoperative adjuvant and very early salvage radiotherapy after prostatectomy in high-risk prostate cancer patients can improve specific and overall survival
    Casas, F.
    Valduvieco, I.
    Oses, G.
    Izquierdo, L.
    Archila, I.
    Costa, M.
    Cortes, K. S.
    Barreto, T.
    Ferrer, F.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2019, 21 (03): : 355 - 362
  • [50] Postoperative adjuvant and very early salvage radiotherapy after prostatectomy in high-risk prostate cancer patients can improve specific and overall survival
    F. Casas
    I. Valduvieco
    G. Oses
    L. Izquierdo
    I. Archila
    M. Costa
    K. S. Cortes
    T. Barreto
    F. Ferrer
    Clinical and Translational Oncology, 2019, 21 : 355 - 362
12345